Dr. First is a senior life sciences executive with over 25 years of experience in the pharmaceutical, biotech, medical device, medical foods and consumer health industries. In the capacity of Founder, Medical Director, VP Global Innovation and New Product Development, CMO, CSO, and Head of R&D, he has initiated and/or supported over 95 clinical and 70+ pre-clinical studies. He has submitted over 175 records of invention and developed them into numerous issued US and International patents over several companies.During his career, he has provided significant pipeline value to more than 35 major brands, including well-known products such as BOTOX®, and Bayer Aspirin®. He has created and commercialized entirely new brands including ReLIZORB® generation 1 and 2 medical devices; leading the design, development, pivotal clinical’s, regulatory and medical affairs strategy, for successful FDA submissions, approvals and successful company exit. Recently, he co-founded a nutritional supplement company, creating and launching a new line of supplements, R3SET® in over 7,500 large national retailer doors in its first year. Dr. First also has considerable executive and consulting experience; leading due diligence on both buy/sell sides, participation in multiple fundraising rounds, road shows, including seed to later stage A-D rounds; interacting with private equity, venture capital and investment banks, as well as regular participation in the Executive Boardroom.
Listed skills include Clinical Development, Pharmaceutical Industry, Clinical Trials, Medical Affairs, and 28 others.